BioNexus Gene Lab Corp Common stock
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $2,260 | $2,137 | $2,523 | $2,630 |
Gross Profit | 368 | 343 | 309 | 326 |
EBITDA | -569 | -618 | -1,288 | |
EBIT | -611 | -658 | -1,337 | |
Net Income | -616 | -623 | -348 | -1,345 |
Net Change In Cash | 2,260 | 2,137 | 2,523 | 2,630 |
Free Cash Flow | -759 | -833 | -73 | -1,654 |
Cash | 814 | 3,595 | 4,377 | 4,137 |
Basic Shares | 1,796 | 1,796 | 1,796 | 1,796 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $9,510 | $9,770 | $10,928 | $13,362 |
Gross Profit | 1,289 | 1,329 | 1,259 | 2,193 |
EBITDA | -1,420 | -2,485 | -185 | 1,164 |
EBIT | -1,573 | -2,593 | -291 | 1,055 |
Net Income | -1,598 | -2,629 | -355 | 751 |
Net Change In Cash | 9,510 | 9,770 | 10,928 | 13,362 |
Cost of Revenue | -509 | |||
Free Cash Flow | -2,461 | -1,971 | 489 | 5 |
Cash | 4,377 | 5,929 | 2,118 | 2,123 |
Basic Shares | 1,781 | 1,722 | 1,440 | 1,426 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$0.34 |
2025-03-31 | -$0.19 |
2024-12-31 | -$0.19 |
2024-09-30 | -$0.74 |
